机构:[1]Guangdong Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Foshan, China.[2]Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY, United States.[3]Central Laboratory, Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, China.[4]Academy of Chinese Medical Science, Henan University of Chinese Medicine, Zhengzhou, China.[5]Department of Pharmacology, New York Medical College, Valhalla, NY, United States.[6]General Nutraceutical Technology, Elmsford, NY, United States.[7]Department of Pediatrics, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.[8]Guangzhou ImVin Pharmaceutical Co., Ltd., Guangzhou, China.[9]Department of Pharmacology, School of Medicine, Yale University, New Haven, China.[10]Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.[11]Department of Otolaryngology, Westchester Medical Center New York Medical College, Valhalla, NY, United States.
This work is supported by Integrative medicine Study (ORA LOG
NO: 012874-101) to X-ML at New York Medical College;
International exchange program in 2018 of Guangzhou University
of Chinese Medicine as well as Guangzhou Science and Technology
Plan Project (706086293043) to KL.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学
第一作者:
第一作者机构:[1]Guangdong Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Foshan, China.[2]Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY, United States.
共同第一作者:
通讯作者:
通讯机构:[2]Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY, United States.[11]Department of Otolaryngology, Westchester Medical Center New York Medical College, Valhalla, NY, United States.
推荐引用方式(GB/T 7714):
Li Ke,Yu Xiu-Hua,Maskey Anish R,et al.Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid[J].Frontiers in pharmacology.2022,13:1042756.doi:10.3389/fphar.2022.1042756.
APA:
Li Ke,Yu Xiu-Hua,Maskey Anish R,Musa Ibrahim,Wang Zhen-Zheng...&Li Xiu-Min.(2022).Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid.Frontiers in pharmacology,13,
MLA:
Li Ke,et al."Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid".Frontiers in pharmacology 13.(2022):1042756